ITULAZAX® versus Alutard SQ® in the treatment of allergic rhinitis induced by pollen from the birch homologous group: A cost‐minimization modeling analysis from the Danish societal perspective

ITULAZAX® versus Alutard SQ® in the treatment of allergic rhinitis induced by pollen from the birch homologous group: A cost‐minimization modeling analysis from the Danish societal perspective

Abstract Background and aims Allergic rhinitis (AR) is an inflammatory disorder triggered by an allergic immune response to inhaled allergens. Birch pollen is the major allergenic tree pollen in parts of Europe. ITULAZAX® is a sublingual immunotherapy tablet for the treatment of adults with moderate...

Full description

Bibliographic Details
Main Authors: Steen M. Rønborg, Tobias Sydendal Grand, Henrik Brandi, Richard F. Pollock
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Clinical and Translational Allergy
Subjects:
administration
allergic
costs and cost analysis
Denmark
desensitization
immunologic
Online Access:https://doi.org/10.1002/clt2.12196

Similar Items

Similar Items